1.. Introduction {#S1}
================

Hearing loss is a significant handicap, affecting communication and impacting quality of life. There are many causes of hearing loss. These include exposure to ototoxic compounds including drugs ([@R77]), mutations in deafness genes ([@R100]), infections such as labyrinthitis or prenatal cytomegalovirus ([@R31]), and aging ([@R120]). Exposure to excessive levels of sound, even for short time periods, can also produce loss of hearing sensitivity and auditory acuity. Noise can lead to temporary threshold shift (TTS) that fully recovers to normal. However, it can also produce losses that fail to return to pre-exposure levels. Such permanent threshold shift (PTS) can have a significant effect on communication and quality of life ([@R108]; accessed 26/06/2016).

Intense sound is a significant cause of hearing loss in the general population, due to occupational and recreational acoustic overstimulation. In fact, noise is one of the most common occupational hazards in the United States. Noise-induced hearing loss (NIHL) significantly affects the military and veterans. Service in the armed forces often involves exposure to noise, and blast exposure has been an increasingly common hazard of military deployment ([@R11]). Blast exposure substantially raises the risk for hearing loss ([@R63]; [@R105]; [@R119]). Veterans who served in the military during the period from 2001 to 2010 are four times more likely than age- and occupation-matched non-veterans to suffer severe hearing loss ([@R13]), and high numbers of active duty military and veterans suffer hearing loss due to service in Afghanistan and Iraq ([@R93]). More than 775,000 veterans had significant hearing loss prior to 2009 ([@R24]), and this number has certainly only increased. The impacts of hearing loss on quality of life, psychological status and employability discussed above are of profound importance to these veterans, impeding their return to civilian life ([@R93]). NIHL also results in substantial disability and rehabilitation expenses.

Due to the impacts on quality of life, extensive attention has rightly been focused on devices that protect the ear from acoustic overstimulation. However, despite decades of efforts, the problem of NIHL continues to grow (e.g. [@R47]), especially among those associated with the military ([@R11]; [@R73]; [@R105]; [@R119]). In part, this problem reflects the resistance of many individuals to wearing noise suppressors such as earplugs with noise-intensive recreation, as well as workplace and military operational constraints which may limit practical sound barrier use, such as combat conditions ([@R11]).

It is therefore important to develop alternative means of NIHL prevention. NIHL primarily reflects damage to the sensorineural structures of the cochlea, especially the sensory hair cells (HCs), but also primary auditory neurons ([@R104]; [@R53]).

There have been many significant advances in our understanding of the cellular processes that mediate the death and survival of HCs. These processes represent potential check-points in cochlear damage mechanisms, at which intervention should be protective. Pharmacological intervention to protect the cochlea therefore has considerable future potential for the protection of hearing from noise.

It is our purpose, in this paper, to review current knowledge relevant to the biology of HC damage and its prevention. To accomplish this, we first review cellular mechanisms that have been found to contribute to NIHL. We then describe protective pathways that act in opposition to these damage pathways. Finally, we review the potential of damage and survival mechanisms as targets for pharmacological intervention to prevent or ameliorate NIHL.

The various molecules discussed in the paper are presented in [Table 1](#T1){ref-type="table"}.

2.. Mechanisms of sensorineural damage in the cochlea {#S2}
=====================================================

2.1.. Mechanisms of TTS {#S3}
-----------------------

Temporary loss of hearing sensitivity is often viewed as a less severe form of the same changes that lead to permanent cochlear damage. However, recent evidence suggests that TTS may be mediated by distinct mechanisms. [@R37] found that low-level TTS is mediated by ion channels that are activated by extracellular ATP, since mice deficient in a specific channel (P2RX2) do not experience TTS after noise exposure that normally causes about 15 dB of temporary sensitivity loss. This ATP receptor is a nonselective cation channel, expressed in cochlear HCs and epithelial cells lining the scala media. Noise is known to stimulate local ATP release in the cochlea ([@R92]). This ATP opens the P2RX2 channels, which then shunt endocochlear current away from the HC transduction channel ([@R94]; [@R62]) and also activates longer-lasting sensitivity reduction via a yet uncharacterized mechanism. Both mice and humans ([@R37]; [@R117]) lacking the *P2rx2* gene that encodes this receptor exhibit increased sensitivity to PTS when exposed to higher levels of noise or long periods of moderate level noise exposure. These findings suggest that low-level TTS, largely arising from P2RX2 receptor activation, may reflect hearing adaptation that extends the intensity range of hearing, and protects the cochlea from damage.

However more extensive, TTS (up to 50 dB) can also recover to normal threshold levels over time ([@R78]), if not to normal levels of synaptic contact between HCs and spiral ganglion neurons ([@R53]). These higher levels of TTS are thus due to additional mechanisms. [@R68] noted that uncoupling of the outer HC stereocilia from the tectorial membrane was the primary morphological feature associated with 43 dB of TTS in animals. Other investigators have noted swelling of the afferent endings underneath the inner HCs after noise exposure, suggestive of excitotoxicity due to the release of excessive glutamate from overstimulated HCs ([@R75]). Supporting this mechanism, [@R75] found that pre-treatment with the glutamate antagonist kynurenate not only prevented this swelling, but also reduced the amount of TTS. This finding suggests that reversible excitotoxicity to cochlear afferent neurons can also contribute to TTS.

Other evidence suggests that metabolic overstimulation may also contribute to temporary changes in threshold after noise. [@R15] found that treatment with the antioxidant D-methionine protected animals from TTS, implicating the generation of reactive oxygen species (ROS) by mitochondria, perhaps in response to metabolic overload. They also found that activity of the ion transporters Na,K-ATPase and Ca-ATPase was decreased, while free radicals were increased, in the cochlear lateral wall after TTS-inducing noise. Given the role of these transporters in generating the endocochlear potential ([@R61]), the decreased activity suggests that reversible reductions in the endocochlear potential may partially mediate TTS.

2.2.. Mechanisms of PTS {#S4}
-----------------------

Given sufficient noise exposure, the ability of the cochlea to recover is overwhelmed, and hearing loss becomes irreversible. Such permanent changes in auditory thresholds have primarily been linked to cochlear HC damage and loss, although damage to neurons and the lateral wall can also mediate long-term loss of hearing ([@R81]). Sufficiently intense overstimulation of the cochlea, as can occur with blast exposure, will produce mechanical damage to the cochlea. This damage includes direct mechanical disruption of HC stereociliary arrays ([@R55]; [@R87]; [@R72]), which can reduce or even eliminate function. The most intense stimulation can even compromise the integrity of the sensory epithelium, disrupting HCs and supporting cells. Moreover, such breaching of the barrier between endolymph and perilymph can expose the basal poles of remaining intact HCs to high levels of potassium, leading to HC death. However, damaging levels of noise begin well below the threshold of such frank mechanical damage. The majority of NIHL reflects HC damage mediated by biochemical processes that occur within the cells themselves.

Until approximately 20 years ago, there was relatively little information on the cellular processes that mediate damage to HCs. However, intensive research on the mechanisms of cell death and survival was ongoing in other disciplines, especially cancer where the regulation of cell death is central to the search for cures. The knowledge gained provided the tools with which to begin understanding the cellular molecular pathways involved in HC damage and loss. More importantly, many of these processes are amenable to pharmacological intervention. Moreover, the cell biological processes that have been implicated in NIHL also appeared to be involved in other forms of HC damage, including ototoxicity ([@R80]) and age-related hearing loss ([@R52]; [@R106]). Thus, any interventions developed for NIHL could also be potentially effective against other forms of sensorineural hearing loss (SNHL), as well. A diagrammatic representation of some of the documented processes that occur within HCs during damage is presented in [Figs. 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}.

2.3.. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) {#S5}
-----------------------------------------------------------------------

A widely accepted mediator of HC damage are ROS (see [Fig. 2](#F2){ref-type="fig"}). These free radicals cause damage by chemically reacting with numerous constituents within cells, including DNA, proteins, cytosolic molecules, cell surface receptors, and membrane lipids, thereby affecting multiple intracellular processes ([@R19]). Generation of free radical species has been observed in the cochlea after exposure to damaging levels of noise ([@R85]; [@R35]; [@R41]; [@R99]), as well as following HC exposure to ototoxic drugs ([@R36]; [@R50]). ROS have been detected in cochlear tissue immediately after noise exposure ([@R114]), indicating that free radical accumulation is an early event in the HC damage process. Free radicals are observed within HCs well before any morphological signs of damage are obvious ([@R16]), further supporting a role in damage initiation. However, ROS can also persist in the cochlea for 7--10 days after noise exposure, spreading from the basal to the apex ([@R114]). Such prolonged oxidative stress can be presumed to induce progressive cochlear injury. Further evidence of a role for ROS in NIHL was provided by [@R57], who observed an association between sensitivity to occupational noise damage and polymorphisms of the gene encoding the endogenous antioxidant enzyme superoxide dismutase 1 (*sod1*) in Chinese workers. With respect to RNS, nitrotyrosine immunoreactivity is a marker of RNS production. It is found to be elevated in rat cochleae six days after PTS-level noise exposure ([@R99]).

Beyond direct biochemical damage, ROS can have indirect effects. [@R115] found that ROS induced lipid peroxidation in the cochlea, including the production of highly toxic products. While lipid peroxidation products themselves can lead to apoptosis, vasoactive lipid peroxidation products such as isoprostanes can potentially lead to the reduced cochlear blood flow that can be associated with excessive noise ([@R95]; [@R83]; [@R69]; [@R46]). Noise-induced ischemia and subsequent re-perfusion might further potentiate the generation of ROS in a positive feedback loop. The reactive nitrogen product peroxynitrite (ONOO--), a particular dangerous free radical which is produced by the combination of nitric oxide (NO) with superoxide, has been observed in the cochlea after noise exposure ([@R115]). ROS can also lead to inflammation, including the production of pro-inflammatory cytokines such as interleukin-6 (IL-6; [@R101]) and tumor necrosis factor á (TNFá; [@R48]), both of which have been observed after ROS generation in the cochlea. These pro-inflammatory mediators can themselves produce cochlear damage ([@R91]).

2.4.. Calcium homeostasis and the generation of ROS {#S6}
---------------------------------------------------

The above data strongly implicate ROS in HC damage, but they do not address the source of free radicals. A primary generator of ROS in cells is the mitochondrion, which generates reactive species as a byproduct of metabolism. Mitochondrial ROS are normally controlled by potent antioxidant enzymes within the mitochondrion, which rely on NADPH as a source of reducing equivalents. Egress of ROS into the cytoplasm is limited by the mitochondrial membrane, including its normal potential. Loss of mitochondrial membrane integrity and/or potential leads to the release of ROS into the cytoplasm, and can also lead to increased free radical production ([@R4]). Calcium homeostasis can play a significant role in regulating this process.

[@R22], [@R23]) found that aminoglycoside antibiotics can induce cytoplasmic ROS in HCs by disrupting calcium homeostasis between the endoplasmic reticulum (ER) and mitochondria. They found that aminoglycosides can enhance the flow of Ca^2+^ from endoplasmic reticulum into mitochondria. The Ca^2+^ release leads to loss of mitochondrial membrane potential and increased membrane permeability.

Free Ca^2+^ has also been found to increase in cochlear HCs immediately after exposure to damaging noise ([@R28]). This increase appears to have several causes, including entry from the extracellular compartment via ion channels such as L-type Ca^2+^ and P2X2 ATP-gated channels. Extracellular Ca^2+^ entry in turn can enhance the release of Ca^2+^ from intracellular stores ([@R71]), further elevating free Ca^2+^. Elevated calcium may not only induce cytoplasmic ROS accumulation, but may also trigger apoptotic and necrotic cell death pathways independent of ROS ([@R71]). In addition, free Ca^2+^ can modulate the activity of mitogen-activated protein kinase (MAPK) and other intracellular signaling cascades that mediate cell stress (e.g., [@R1]; [@R33]). In fact, there is extensive evidence that MAPK cascades play a significant role in damage to HCs ([@R58]).

Another source of ROS in noise are NADPH oxidases. These enzymes generate the ROS superoxide under conditions of cell stress. [@R6] found that intracochlear treatment of animals with an NADPH oxidase inhibitor reduced noise-induced PTS.

2.5.. Cell signaling networks as mediators of HC damage {#S7}
-------------------------------------------------------

Cell signaling pathways connect the processes of cells and ultimately link them to the cell nucleus, activating gene expression programs that can be powerful determinants of cell fate. Amongst the various cell signaling pathways, the MAPKs are important mediators of damage and survival signaling. They act downstream from plasma membrane receptors, intracellular receptors, and ROS ([@R109]; [@R97]), linked sequentially via intermediate signaling proteins, including members of the Src, Ras, Rac/cdc42, and mixed lineage kinase protein families, to the activation of gene expression. When phosphorylated, MAPKs in turn phosphorylate elements of the AP-1 transcriptional complex, leading to the transcription of diverse genes. They also interact with other target proteins that can directly regulate intracellular processes. MAPK activation can influence cell proliferation, differentiation, motility, cell death and cell survival. The MAPKs include the extracellular signal-regulated kinases 1, 2 and 5 (ERK1, 2 and 5), most often induced by growth factors and mediates tissue growth and survival. Stress-activated MAPKs include c-Jun-N-terminal kinase (JNK) isoforms 1--3, and p38 MAPK (isoforms á, â, ã and ä). These stress-activated MAPKs act in key pathways mediating cellular stress and inflammation responses evoked by a variety of physical, chemical and biological stress stimuli. Strong and sustained activation of the stress MAPKs can lead to apoptotic or necrotic cell death.

Intense noise has been found to alter cochlear MAPK phosphorylation that is linked to HC death. [@R65] observed JNK activation in the organ of Corti after impulse noise exposure, followed by positive TUNEL labeling indicative of apoptosis. [@R58] also noted increased organ of Corti JNK phosphorylation within hours of intense noise stimulation, leading to increased c-Jun phosphorylation. Increased HC c-Jun phosphorylation was also noted after noise exposure by [@R2]. Inhibitors of JNK have demonstrated protection against both noise-induced and aminoglycoside-induced HC loss ([@R74]; [@R103], [@R102]). In addition, mice in which c-Jun phosphorylation sites were mutated showed partial protection against noise trauma ([@R2]). Inhibition of upstream activators of the JNK pathway, including KRas, Rac/cdc42 and mixed lineage kinases also provides HC protection ([@R8], [@R9]; [@R5]), delineating the pathway leading to JNK activation.

2.6.. Programmed cell death {#S8}
---------------------------

Following intense noise exposure activation of ROS, RNS and MAPK stress pathways, cochlear HCs can undergo apoptosis and/or necroptosis ([@R38], [@R39], [@R40]; [@R67]; [@R103]; [@R118]). Apoptosis occurs through the sequential actions of caspases, initiated by their associated extrinsic and intrinsic pathways ([@R112]). The extrinsic pathway is activated by extracellular stimuli such as TNFα through transmembrane death receptors, which cleave caspase-8 and activate downstream execution mediated by caspases 3 and 7. The intrinsic pathway ([Fig. 2](#F2){ref-type="fig"}) is initiated by a change in mitochondrial membrane permeability. Increased permeability releases not only ROS, as discussed above, but also cytochrome C. Cytochrome C binds with Apaf-1 to form an apoptosome, which activates caspase-9 and the downstream apoptotic execution pathway. There are also caspase-independent processes that lead to apoptosis, mediated by other factors including receptor-interacting serine/threonine-protein kinase 1 (RIP-1) or AIF ([@R90]). The Bcl-2 proteins play an important role in regulating apoptosis. Pro-apoptotic family members such as Bax and Bak, promote apoptosis, while anti-apoptotic members such as Bcl-2 and Bcl-xL inhibit apoptosis. RIP-1 can also initiate the process of necroptosis, which differs from apoptosis both in initiation and effect. Apoptosis results in the orderly disassembly of cells into membrane-packaged fragments that can be disposed of by phagocytes in a non-inflammatory process. Necroptosis permeabilizes intra- and extracellular membranes, releasing cellular and organelle contents into the extracellular medium, where they induce inflammation.

The caspase-mediated cell death pathway has been widely implicated in programmed death of HCs ([@R67]; [@R118]; [@R10]; [@R89]), with the preponderance of evidence implicating the intrinsic pathway (e.g., [@R88]; [@R22], [@R23]), but there is also evidence for extrinsic pathway involvement ([@R9]), as well as the participation of necroptosis ([@R121]). [@R116] found that while TTS-inducing levels of noise up-regulated anti-apoptotic Bcl-xl in HCs, PTS-inducing levels of noise up-regulated pro-apoptotic Bak.

2.7.. Inflammatory mediators {#S9}
----------------------------

Stress signaling also regulates the expression of inflammatory mediators. Both apoptosis and ROS generation trigger inflammation. Noise exposure has been shown to up-regulate cochlear production of cytokines such as IL-6 ([@R29]; [@R101]) and chemotactic chemokines that attract inflammatory cells to the cochlea ([@R96]). Generation of these mediators can occur via activation of the nuclear factor kappa B (NF-κB) signaling cascade, leading to cytokine production ([@R113]). Alternatively, noise induced HC ischemia can trigger the stabilization of cochlear HIF-1α (hypoxia inducible factor). This transcription factor in turn triggers the increased expression of pro-inflammatory TNFα and suppresses the protective factor IGF1 ([@R76]). The ability of cytokines such as TNFα to produce HC loss is well documented (e.g. [@R43]).

Another potential source of inflammatory mediators is the release of intracellular components into the extracellular environment. Such release is particularly the case with necrosis or necroptosis, both of which have been implicated in cochlear noise damage ([@R121]). Some intracellular components comprise damage-associated molecular patterns (DAMPs), which can initiate inflammation through interaction with specific receptors. These include the Toll-like receptors (TLRs), which also mediate innate immunity to pathogens, and receptor for advanced glycation endproduct (RAGE). Binding of a variety of DAMPs to TLRs or RAGE leads to the activation and nuclear translocation of NF-κB, a transcription factor that produces the transcription of a variety of inflammatory cytokine genes. [@R59] found that NF-κB was activated 2--6 h after PTS-inducing noise, consistent with damage signaling. DAMP signaling can also activate the stress MAPKs JNK and p38. [@R98] found that mice deficient in TLR4 exhibited reduced NIHL and HC damage after noise exposure. The levels of IL-6 production were also reduced within the organ of Corti, but not in the lateral wall. Since noise exposure presumably does not induce cochlear infection, this study strongly implicates inflammation induced by DAMP signaling as a contributor to NIHL. Interestingly, [@R20] noted that preventing damage to cochlear synapses by treatment with an NMDA antagonist and a neurotrophin reduced noise-induced HC loss. At the time, the link between neural damage and HC survival was unclear ([@R79]). However, it seems likely that DAMP signaling from injured cochlear synapses may contribute to HC damage.

Finally, the production of pro-apoptotic proteins can serve to amplify cellular damage, by de-stabilizing the mitochondrial membrane and increasing the release of ROS ([@R86]), creating a positive feedback loop that enhances the transition of cells into programmed cell death.

3.. Survival signaling and the negative regulation of HC damage {#S10}
===============================================================

As one would expect, the cellular processes that lead to damage and death are tightly regulated. For virtually all of the processes that contribute to cell damage, there are opposing rescue processes that occur concurrently, aiming to restore physiological balance. Only when these survival-promoting mechanisms are overwhelmed that cellular damage leads to cell death.

One such balancing act is cochlear signaling via the P2X2 ATP receptor, as described above. It reduces the effects of noise just above the potentially damaging level, resulting in TTS and extending the range at which the cochlea can encode intensity without damage. This response also serves to protect the cochlea from higher levels of noise, resulting in reduced PTS ([@R37]). For example, Chinese families with a *P2rx2* mutation that silences the P2X2 receptor channel experience accelerated hearing loss when exposed to elevated environmental noise levels ([@R117]).

The accumulation of ROS in cells is opposed by the action of native antioxidant enzyme systems, and HCs are no exception to this process. Glutathione, superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase, glutathione reductase and coenzyme Q~10~ have all been detected in cochlear tissues ([@R45]; [@R60]; [@R25]). These natural defenses must be overcome by ROS before damage is initiated. Interestingly, [@R84] found that the antioxidant glutathione in the organ of Corti was distributed in a high-to-low gradient from apex to base. This distribution may help to explain the familiar pattern of HC damage due to several causes, with initial appearance in the base and progressive extension toward the apex. [@R25] found cochlear coenzyme Q~10~ to be reduced for 10 days by exposure to 60 min of 100 dB SPL noise. They also noted that pre-administration of exogenous CoQ~10~ improved post-exposure hearing thresholds, and also reduced HC bundle disorientation and SGN loss.

Similarly, calcium homeostasis in HCs is maintained by intra- and extracellular active transport systems ([@R30]; [@R49]) and Ca^2+^ buffering proteins such as oncomodulin, calbindin, calretinin, and parvalbumins, with which the HC is well supplied ([@R32]). These resist the buildup of cytoplasmic calcium unless overwhelmed by release from mitochondria and other stores such as the endoplasmic reticulum.

There are also cell signaling pathways that oppose the JNK-MAPK and other stress pathways within the HC. [@R5] identified Ras as a G-protein activated during ototoxin treatment of the organ of Corti, and therefore evaluated the effects of Ras inhibition on HC loss. High levels of the Ras inhibitor FTI-277 were protective, consistent with reducing downstream JNK signaling. However, lower levels of the inhibitor actually enhanced HC loss. This paradoxical finding is related to the differential sensitivity of Ras isoforms to FTI-277. High concentrations inhibit kRas, which leads to JNK activation, while low levels of FTI-277 inhibit another Ras isoform, hRas, which is known to activate an alternative MAPK, extracellular regulated kinase (ERK; [@R82]). ERK is associated with cell survival and proliferation in other tissues ([@R110]; [@R111]). This finding suggests that ototoxins activate two distinct and competing cell signaling pathways within HCs. The balance of signaling between these pathways plays a significant role in determining the cellular fate.

ERK signaling is frequently activated by growth factors, which may also explain why several growth factors have been shown to protect HCs from noise damage, including insulin-like growth factor 1 ([@R44]), hepatocyte growth factor ([@R42]) and transforming growth factor beta ([@R66]). Interestingly, mutations in the insulin-like growth factor 1 (*igf1*) gene cause syndromic hearing loss in both humans and mice ([@R12]), further supporting the role of growth factors in protecting hearing. More direct evidence of the role of hRas and ERK in HC survival is provided by the observation that inhibition of MEK, which links hRas to ERK activation, is toxic to HCs ([@R17]).

Another well-recognized survival signaling pathway is mediated by phosphatidylinositol 3 kinase (PI3K), protein kinase c (PKC) and protein kinase B (also known as AKT), which can also be activated by growth factors. [@R14] found that blocking PI3K/AKT signaling increased sensitivity to NIHL in animals.

4.. Implications for pharmacological intervention {#S11}
=================================================

Since NIHL is frequently a predictable form of hearing loss, therapeutic intervention for its prevention is feasible. There are at least two potential strategies for therapeutic intervention to reduce cochlear damage. One is to inhibit processes or pathways that lead to the damage of cochlear cells. The other is to enhance processes that enhance cochlear cell survival. Both of these strategies have been attempted with varying degrees of success (see reviews in [@R70]; [@R107]; [@R64]).

Antioxidants are promising therapeutic interventions, and have been investigated as prophylaxis to enhance cochlear defense against noise-induced ROS. Systemic or locally applied antioxidants have been shown to protect HCs and hearing from noise damage in animals (e.g. [@R7]; [@R27], [@R26]; [@R54]) and mice engineered to overexpress natural antioxidant enzymes such as superoxide dismutase are less sensitive to HC damage ([@R18]). The elevation of RNS observed in the cochlea after noise was found to be mitigated by treatment with the adenosine A1 receptor agonist adenosine amine congener (ADAC; [@R99]). Systemic treatment with ADAC up to 24 h after noise exposure resulted in lower nitro-tyrosine immunore-activity in the cochlea, reduced HC loss, and lower levels of PTS.

Translation of these promising animal antioxidant studies to prevent noise damage in humans has been difficult. For one thing, clinical studies of HC protection are difficult to perform, since stimulation with potentially damaging levels of noise typically cannot be used on human subjects. It is also impossible to examine pathology, so outcome measures are restricted to hearing thresholds. When human protection studies have been performed, the results have been mixed. A trial of the antioxidant N-acetyl cysteine (NAC) in military trainees also showed some degree of protection ([@R56]). In contrast, a recent trial of NAC versus placebo treatment prior to stapedectomy, where drilling noise and surgical trauma can produce SNHL, showed an equivalent level of hearing loss (\~10 dB) in both groups, and thus was unable to demonstrate a distinct protective effect ([@R3]). [@R51] found no effect of NAC on TTS induced by loud music in young adults.

Given the demonstrated role of the MAPK-JNK signaling pathway in acoustic trauma as described above, animal studies have investigated the use of pharmacological blockers to protect HCs and hearing from damage. [@R74] used an inhibitor of mixed lineage kinases to prevent JNK activation, and observed reduced NIHL and HC loss. A peptide inhibitor of JNK signaling, D-JNKI-1, has also been shown to protect the cochlea against noise-induced HC and hearing loss when delivered directly into the scala tympani or locally to the round window membrane ([@R103], [@R102]; [@R21]). No clinical trials of JNK inhibition for noise protection have been reported, however.

Reduction of inflammation also has the potential to protect against NIHL. The TNFá inhibitor etanercept has been shown to reduce noise-induced threshold shifts in animals ([@R103]). Similarly, [@R101] found that a neutralizing anti-IL-6-receptor antibody protected mice from NIHL. The anti-inflammatory steroid dexamethasone, delivered to the round window membrane, has also been shown to reduce hearing loss after noise ([@R34]). [@R122] treated patients suffering recently (3 days to two weeks) from NIHL with systemic plus intratympanic dexamthasone, and compared them to patients receiving systemic steroid alone. The patients receiving intratympanic treatment showed significantly more improvement in thresholds.

Stimulation of HC survival signaling is another potential means of rescuing HCs and hearing. The animal studies demonstrating protection from NIHL by growth factors, as reviewed above, provide evidence supporting pro-survival compounds as potential interventions. No human trials of growth factors to protect against NIHL have yet been performed.

Of course, there are other issues to be considered in addition to effectiveness when considering pharmacological intervention. Many of the compounds used in animal studies to reduce HC death from noise and other causes could have undesirable effects if delivered systemically. MAPK inhibitors or stimulants, apoptosis inhibitors or growth factors all would be expected to influence cells in other body tissues if delivered systemically. This potential for side effects has led to the adoption by physicians and researchers of local delivery to the inner ear, typically via delivery to the middle ear allowing transit across the round window membrane into the perilymph. This option provides the possibility to utilize a wider variety of potential therapies for inner ear protection from noise.
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![Diagram illustrating damage processes and pathways thought to contribute to HC loss due to acoustic overexposure.\
Noise initiates the production of ROS via release of Ca^2+^ from the endoplasmic reticulum and/or entry from extracellular fluid, which induces release of ROS from mitochondria, and by activation of NADPH oxidases. ROS can activate NF-κB, leading to the production of pro-inflammatory cytokines, and also κRas/cdc42/JNK pathway leading to the expression of stress and apoptosis genes. Pro-apoptotic factors further increase mitochondrial membrane permeability, leading to the release of additional ROS. The JNK pathway can be inhibited by the ERK MAPK or AKT, signaling molecules that can be activated by growth factors.](nihms-1046964-f0001){#F1}

![Diagram of the intrinsic pathway of apoptosis.\
Apoptosis can be initiated when pro-apoptotic proteins such as BAX or BAD which overwhelm anti-apoptotic proteins of the BCL family. This destabilizes mitochondrial membranes, releasing Cytochrome *c* into the cytoplasm. Interaction of Cytochrome *c* with APAF forms an apoptosome, which enzymatically cleaves pro-caspase 1 into its active form. This initiator caspase in turn cleaves executor caspases (3, 6 and 7), which mediate programmed death and orderly fragmentation of the cell.](nihms-1046964-f0002){#F2}

###### 

Selected molecules relevant NIHL.

  -----------------------------------------------------------------------
  **Damage mediators**
   Free radicals
    Reactive oxygen species (ROS)
    Reactive nitrogen species (RNS)
   Intracellular free Ca^2+^
   Nicotoinamide adenine dinucleotide phosphate oxidase (NADPH oxidase)
   Pro-inflammatory cytokines
    Interleukin 1 beta (IL-1β)
    Interleukin 6 (IL-6)
    Tumor necrosis factor alpha (TNFα)
  **Damage signaling molecules**
   Nuclear Factor kappa B (NF-κB)
   Focal adhesion kinase (FAK)
   Src
   Kirsten rat sarcoma viral oncogene homolog (kRas)
   Ras-related C3 botulinum toxin substrate (Rac)
   Cell division control protein 42 (Cdc42)
   Mixed lineage kinases (MLKs)
   Jun amino-terminal kinase (JNK)
   Jun
   Activator protein 1 (AP-1)
  **Apoptosis pathway molecules**
   Bcl2 Associated X (Bax)
   Bcl2 Associated death promoter (Bad)
   B cell lymphoma 2 (Bcl2)
   Bcl2 related gene (Bclx)
   Cytochrome C
   Apoptotic protease activating factor 1 (APAF)
   Caspase 1
   Caspases 3,6,7
  **Protective molecules**
   Antioxidants
   Growth factors (GFs)
   Harvey rat sarcoma oncogene (hRas)
   Phosphinositol 3 kinase (PI3K)
   Protein kinase B (PKB or AKT)
   Extracellularly regulated kinase (ERK)
  **Pharmacological protectants**
   N-acetyl cysteine (NAC) (antioxidant)
   FTI-277 (inhibitor of KRas at 10 μM; hRas at 1 μM)
   Adenosine A1 receptor agonist adenosine amine congener (ADAC)
   D-JNKI-1 (peptide JNK inhibitor)
   Etanercept (TNFα inhibitor)
   Anti-IL-6-receptor antibody
   Dexamethasone (steroid)
  -----------------------------------------------------------------------
